Africa Corporate Wellness Market, by End User, 2018-2027
| Label | USD Million |
|---|---|
| 2018 | 339.49257184687303 USD Million |
| 2019 | 359.3300209578692 USD Million |
| 2020 | 381.07571621492013 USD Million |
| 2021 | 404.9640672018295 USD Million |
| 2022 | 432.215198405062 USD Million |
| 2023 | 462.35657931577873 USD Million |
| 2024 | 495.77591319125014 USD Million |
| 2025 | 532.9229705326444 USD Million |
| 2026 | 574.3210671144443 USD Million |
| 2027 | 620.5809411024144 USD Million |
| 2028 | 670.3766810680402 USD Million |
| 2029 | 726.2419431868894 USD Million |
| 2030 | 758.9839007347601 USD Million |
| 2031 | 822.2331853927055 USD Million |
| 2032 | 890.7532959612784 USD Million |
Data Source: Wantstats Repository
Market Dynamics
Spain Dry Eye Syndrome (DES) is a common chronic disorder that affects the eyes. It is characterized by inadequate tear production and/or an imbalance of the tear components, resulting in dryness of the eye surfaces. This dryness causes inflammation and can lead to serious eye discomfort and visual problems. DES can be caused by various factors, including aging, various health conditions and environmental factors, such as prolonged exposure to air-conditioned and windy environments. DES is believed to affect around 15 percent of the Spanish population. It is the most commonly diagnosed ocular condition in the elderly with a prevalence rate of 34-43 percent among those aged 65 and over. The etiology of DES, the exact cause, remains unknown. Genetics, environmental exposure to chemicals and drugs, hormone fluctuations, smoking, and lifestyle factors such as diet and excessive use of contact lenses all contribute to DES. To diagnose DES, the patient must undergo an ophthalmologic consultation as well as slit-lamp biometry to measure tear production, tear-film analysis to assess the stability of the tear film, staining with dyes to highlight corneal damage, endothelial cell counts performed through specular microscopy, and various other tests.
Treatment entails using artificial tears, modifying lifestyle habits, topical antibiotics, topical cyclosporine, and systemic therapy. DES in Spain is supported by various resources, such as educational campaigns to make patients aware of the disease, government resources to enable new treatment options, and the support of the Spanish ophthalmology society, which has been actively involved in the development of consensus guidelines to provide best practices for treatment. Additionally, Spanish companies are involved in research and collaboration with universities and hospitals, with various clinical trials being conducted in the country to develop improved treatments. Going forward, Spain Dry Eye Syndrome (DES) will benefit from emerging trends, such as advancements in smart ophthalmic diagnostics and monitoring systems, development of personalized DES treatments, use of artificial intelligence, and artificial tears that mimic the human tear film. Despite the lack of a single cure, effective diagnostics and treatments are available that can make DES bearable on a daily basis. With increased awareness, better diagnostics, and improved treatments, DES can become a manageable health condition for those in Spain.
Research Methodology
Figures reflect Wantstats’ original market research and forecasting models, compiled as part of the Wantstats research archive and published in 2023.
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
Powering the world's best teams.
From next-gen startups to established enterprises.
Get in Touch
Let's work together
support@wantstats.comSee our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence



